This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Pharma-exclusive Webinar: The 2025 Pharma Toolkit for Virtual Medical Education About the webinar Step into the future of medical education with our exclusive webinar series from February 25-26, designed specifically for Pharma leaders. Transform your approach and lead the curve in training!
Acquisition highlights companies shared commitment to clients, workplace culture, and attracting the industrys best people TORONTO, ON/SARATOGA SPRINGS, NY January 7, 2025 Klick Health today announced it has acquired Peregrine Market Access, a leading market access strategy and value communications specialist in life sciences.
To learn more about how Clarivate and CMR International help pharmas future-proof their portfolios, please visit us here. Jasmin Mehta is a Senior Manager within the Life Science ProfessionalServices team at Clarivate. The post Pharma R&D productivity dips, but efficiency gains give hope appeared first on Clarivate.
Primary packaging for vaccines As one of the pharmaceutical divisions of the Group, IMA Life leads the global market, taking care of the design and development of complete aseptic lines for parenteral products with or without freeze-drying requirements. Isolation technologies and other containment solutions are also part of our expertise.
Everyone knows that over the next few weeks and months, businesses in the pharma marketing industry will meet to discuss next year’s budget. Is it possible to increase product revenues, contact more leads, extend product life cycles, and make work easier? How PharmaKinnex Helps You Plan For A Better 2023 September 27, 2022.
That’s the leading 7 including Rave and Clinical One. Our ProfessionalServices team is here to support you. That’s a big tick in the quality box, as well as saving even more time. What about EDC build? Formedix lets you build, preview, and validate studies for most EDC systems. And if you need a helping hand along the way?
53% of pharma CEOs report regulatory changes as a top disruptive trend* Gedeon Richter had a need to streamline regulatory monitoring and impact assessments. Our client is a major pharmaceutical company headquartered in Budapest, Hungary, with an expanding presence in Western Europe, Mainland China, Latin America and Australia.
Our list of recent hires and promotions in key positions at Pharma, Life Sciences, and Healthcare companies. In her new role, she will oversee Avalere’s global marketing team to build meaningful connections and create customized strategic solutions for clients, ultimately driving growth and leading to new opportunities for the organization.
A: Most of the pharma companies that work with us are actually going to be more in the specialty space but I’ll use your example. The conversation would be mainly for you to understand what is the role of digital therapeutics within pharma. “What am I trying to achieve? I am trying to get my patients to be well supported.
SUMMARY: Allowing Medicare to negotiate drug prices is popular with voters because the media has been focused on the high price of some drugs, but this measure won’t lead to lower healthcare costs. The drug industry is trying to convince voters that government negotiations with drug companies will lead to less innovation.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content